Gene · 7337
Papers4,306
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
121 to 140 of 4,306
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| The TP53 "rs 1042522″ Polymorphism and its association with precancerous cervical lesions progression among Tunisian women. | Diagn Microbiol Infect Dis | 2025 | 40609119 | PubTator, text mining | PubMed |
| Loss of UBE3A impacts both neuronal and non-neuronal cells in human cerebral organoids. | Commun Biol | 2025 | 40447862 | PubTator, text mining | PubMed |
| Small Molecule-Induced Alterations of Protein Polyubiquitination Revealed by Mass-Spectrometric Ubiquitome Analysis. | Angew Chem Int Ed Engl | 2025 | 40444580 | PubTator, text mining | PubMed |
| Generation of two pairs of induced pluripotent stem cells from Angelman syndrome patients with class I 15q11.2-q13.1 deletions and their unaffected familial controls. | Stem Cell Res | 2025 | 40435553 | PubTator, text mining | PubMed |
| Novel method for detection of UBE3A protein in CSF from individuals with Angelman syndrome. | Mol Genet Metab | 2025 | 40411957 | PubTator, text mining | PubMed |
| Autism and intellectual disability due to a novel gain-of-function mutation in UBE3A. | J Hum Genet | 2025 | 40316779 | PubTator, text mining | PubMed |
| Identification of E3 Ubiquitin Ligase Substrates Using Biotin Ligase-Based Proximity Labeling Approaches. | Biomedicines | 2025 | 40299435 | PubTator, text mining | PubMed |
| Clinical Efficacy and Safety of the Ketogenic Diet in Patients with Genetic Confirmation of Drug-Resistant Epilepsy. | Nutrients | 2025 | 40290041 | PubTator, text mining | PubMed |
Virtual Screening, Molecular Docking and Molecular Dynamics Simulation of Bioactive Compounds from Various Indonesian Medicinal Plants as Potential Inhibitors of Human Papillomavirus Type 16 E6 Protein in Cervical Cancer Development. | Trop Life Sci Res | 2025 | 40276043 | PubTator, text mining | PubMed |
| The essential role of E3 ubiquitin ligases in the pathogenesis of neurodevelopmental and psychiatric disorders: Cul3, Cul4, Ube3a, and ZNRF1. | Biochem Biophys Res Commun | 2025 | 40233431 | PubTator, text mining | PubMed |
| Evolution of genome-wide methylation profiling technologies. | Genome Res | 2025 | 40228903 | PubTator, text mining | PubMed |
| Loss function of tumor suppressor FRMD8 confers resistance to tamoxifen therapy via a dual mechanism. | Elife | 2025 | 40213945 | PubTator, text mining | PubMed |
| Localization of human UBE3A isoform 3 is highly sensitive to amino acid substitutions at p.Met21 position. | Hum Mol Genet | 2025 | 40211773 | PubTator, text mining | PubMed |
| Lower respiratory rate during sleep in children with angelman syndrome compared to age-matched controls. | Orphanet J Rare Dis | 2025 | 40200228 | PubTator, text mining | PubMed |
| Therapeutic potential of allosteric HECT E3 ligase inhibition. | Cell | 2025 | 40179885 | PubTator, text mining | PubMed |
| Molecular aspects of Angelman Syndrome: Defining the new path forward. | Biomol Biomed | 2025 | 40138703 | PubTator, text mining | PubMed |
| A Combination of Flavonoids Suppresses Cell Proliferation and the E6 Oncogenic Pathway in Human Papillomavirus-Transformed Cells. | Pathogens | 2025 | 40137706 | PubTator, text mining | PubMed |
| Age-Related Trajectories of Autistic Traits in Children With Angelman Syndrome. | Autism Res | 2025 | 40116126 | PubTator, text mining | PubMed |
| A long journey to the discovery of nuclear receptor coactivator existence, physiology, pathology, and therapy. | J Biol Chem | 2025 | 40090583 | PubTator, text mining | PubMed |
| YTHDC1 negatively regulates UBE3A to influence RAD51 ubiquitination and inhibit apoptosis in colorectal cancer cells. | Sci Rep | 2025 | 40087295 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/7337/papers?page=7